Effects of Modified Tobacco Risk Products with Claims and Nicotine Features on Perceptions among Racial and Ethnic Groups
-
Published:2023-07-27
Issue:15
Volume:20
Page:6454
-
ISSN:1660-4601
-
Container-title:International Journal of Environmental Research and Public Health
-
language:en
-
Short-container-title:IJERPH
Author:
DeAtley Teresa1ORCID, Johnson Andrea C.1ORCID, Stone Matthew D.2ORCID, Audrain-McGovern Janet1ORCID, Mercincavage Melissa1ORCID, Strasser Andrew A.1ORCID
Affiliation:
1. Department of Psychiatry and Tobacco Center of Regulatory Science, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA 2. Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, CA 92093, USA
Abstract
Research suggests consumers may misunderstand modified risk tobacco product (MRTP) claims. We examined the effects of nicotine content across four tobacco products with and without MRTP claims among a racially and ethnically diverse sample of adults who do and do not smoke. Adults (n = 1484) aged 21–65 completed an online experiment using a 2 × 2 × 4 mixed factorial design to examine the effects of tobacco product (Classic White Snus, IQOS, JUUL e-cigarette, and VLN cigarette) and nicotine content (high vs. low) stratified by MRTP claim (present vs. absent) across four outcomes: (1) likely to try (2) serious disease if used regularly, (3) least addictive, and (4) ease of quitting smoking. Not including an MRTP claim resulted in an increased likelihood of trying a product, decreased concern of serious disease, lower perceived addictiveness, and increased ease of quitting smoking. Participants selected low nicotine IQOS without a claim as the least likely to cause serious disease. Low nicotine JUUL, without a claim, was selected as least addictive and most likely to facilitate quitting. Intentions to try were highest for low nicotine JUUL. Participants selected low-nicotine products as less addictive than high nicotine products. Regulatory efforts should consider how MRTP claims interact with different product characteristics. Subtle differences exist across outcomes between racial and ethnic groups, which indicates that further research is warranted.
Funder
National Cancer Institute
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference46 articles.
1. Food and Drug Administration (2022, November 23). Section 911 of the Federal Food, Drug, and Cosmetic Act-Modified Risk Tobacco Products. FDA. Published Online 21 July 2020, Available online: https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/section-911-federal-food-drug-and-cosmetic-act-modified-risk-tobacco-products. 2. Food and Drug Administration (2022, September 28). Modified Risk Granted Orders. FDA. Published Online 15 August 2022, Available online: https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-granted-orders. 3. Wackowski, O.A., Rashid, M., Greene, K.L., Lewis, M.J., and O’Connor, R.J. (2020). Smokers’ and Young Adult Non-Smokers’ Perceptions and Perceived Impact of Snus and E-Cigarette Modified Risk Messages. Int. J. Environ. Res. Public Health, 17. 4. Effects of IQOS health warnings and modified risk claims among young adult cigarette smokers and non-smokers;Mays;Tob. Control,2023 5. Rubenstein, D., Denlinger-Apte, R.L., Cornacchione Ross, J., Carroll, D.M., and McClernon, F.J. (2023). Older age is associated with greater misperception of the relative health risk of e-cigarettes and cigarettes among US adults who smoke. Tob. Control, Epub ahead of printing.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|